Introduction of BONITAR
400 TABLET:

BONITAR 400
TABLET is an oral targeted therapy used for managing Philadelphia chromosome
-positive chronic myeloid leukemia (Ph+ CML) in adult patients. It works by
blocking specific proteins called tyrosine kinases, which are responsible for
the uncontrolled growth of leukemia cells.

By inhibiting
these proteins, bosutinib helps slow or stop the progression of cancer,
improving long-term outcomes for patients who may not have responded well to
other treatments.

This medication
is usually taken once daily with food to enhance absorption and reduce the risk
of stomach-related side effects. It is essential to follow the prescribed
dosage carefully and attend regular medical check-ups to monitor blood counts,
liver function, and overall response to therapy.

Grapefruit and
grapefruit juice should be avoided, as they can increase the risk of side
effects by affecting how bosutinib is processed in the body.

While BONITAR 400
TABLET is an effective therapy, it can cause side effects such as diarrhea,
nausea, liver enzyme abnormalities, and low blood cell counts. Patients should
inform their doctor about any existing health conditions, including liver,
kidney, or heart problems, to ensure safe use.

Regular
monitoring and supportive care can help manage potential side effects,
improving the overall treatment experience. Always consult a doctor before
starting or stopping bosutinib to ensure it is suitable for your condition.

Uses of BONITAR 400 TABLET:

Blood Cancer

How to use BONITAR 400 TABLET:

Always follow
your doctor's instructions regarding bosutinib therapy. Do not adjust the dose
or discontinue the medication without consulting your doctor.